Teligent Inc. (TLGT) had a rough trading day for Tuesday April 16 as shares tumbled 14.12%, or a loss of $-0.1412 per share, to close at $0.86. After opening the day at $1.01, shares of Teligent Inc. traded as high as $1.01 and as low as $0.82. Volume was 2.02 million shares over 5,904 trades, against an average daily volume of n/a shares and a total float of 53.77 million.
As a result of the decline, Teligent Inc. now has a market cap of $46.18 million. In the last year, shares of Teligent Inc. have traded between a range of $4.52 and $0.86, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets.
Teligent Inc. is based out of Buena, NJ and has some 189 employees. Its CEO is Jason Grenfell-Gardner.